Aptamer Group plc (LON:APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has announced that it has conditionally raised £2.83 million (before expenses), by way
Guardant Health Japan Corp announced its submission of a regulatory application to Japan’s Ministry of Health, Labour and Welfare (MHLW) for the approval of the Guardant360® CDx comprehensive genomic profiling
In May, nearly half a million people in Greater Manchester were on NHS waiting lists, almost double the number before the Covid-19 pandemic. According to the latest figures from the
Clinical trials are essential for advancing medicine, enhancing drug discovery, and improving patient safety. There are two main types of clinical trials: observational and interventional. Understanding these types helps researchers
One Health Group plc (AQSE:OHGR) Chairman Derek Bickerstaff caught up with DirectorsTalk for an exclusive interview to discuss how the company can help fix the NHS, how their corevalues are
The pharmaceutical sector continues to experience robust growth, driven by a surge in innovative research, the advent of advanced technologies, and an increasing global demand for effective healthcare solutions. This
A new analysis by the health testing company Forth reveals a dramatic surge in the number of NHS patients in England waiting 18 or more weeks for gynaecology treatment. Over
hVIVO’s CEO addressed the Canary Wharf group, discussing their world-leading title in human challenge trials and the company’s relocation to Canary Wharf. Yamin ‘Mo’ Khan emphasised hVIVO’s fit-for-purpose facility, featuring
Hvivo, a Dublin and London-listed pharmaceutical services company, reported a record revenue for the first half of the year, continuing its momentum in the market. Specialising in testing infectious and
The waiting list for routine hospital treatment in England has increased for the second month in a row, according to the latest figures. At the end of May, an estimated
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
